Continuous Glucose Monitoring System (CGMS)

DEVICE5 trials

Sponsors

Jaeb Center for Health Research, University Hospital, Strasbourg, France, Yale University, University of Maryland, Baltimore

Conditions

AgingCognitive DeclineCystic FibrosisDepressionDiabetesDiabetes MellitusDiabetes Mellitus, Insulin-DependentFunctional Status

Phase 4

Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer

CompletedNCT00069628

Jaeb Center for Health ResearchDiabetes Mellitus, Insulin-Dependent

Start: 2003-07-31End: 2004-11-30Target: 200Updated: 2016-09-05

Assessing Continuous Glucose Monitors in Healthy Children

CompletedNCT00069602

Jaeb Center for Health ResearchDiabetes Mellitus

Start: 2002-08-31End: 2002-11-30Target: 20Updated: 2016-09-05

Unknown Phase

Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis

CompletedNCT00476281

University Hospital, Strasbourg, FranceCystic Fibrosis, Diabetes

Start: 2008-04-30End: 2020-01-31Updated: 2020-04-28

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

CompletedNCT02673203

Yale UniversityDiabetes

Start: 2016-02-29End: 2017-12-14Updated: 2022-05-05

Glucose Variability and Cognition in Prediabetes

RecruitingNCT04201600

University of Maryland, BaltimoreAging, Cognitive Decline, Depression +3

Start: 2022-03-01End: 2026-12-31Target: 30Updated: 2025-03-30

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.

2013-12-1776 citations